Other specified type of carcinoma in situ of right breast refers to a non-invasive breast cancer that is localized and has not spread beyond the ducts or lobules. This condition is clinically significant as it requires careful monitoring and management to prevent progression to invasive cancer. The ICD-10 Code D05.81 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient outcomes.
ICD-10 Code D05.81 represents a diagnosis of Other specified type of carcinoma in situ of right breast, indicating a specific form of non-invasive breast cancer. This code should be used when documenting cases that do not fit into more common categories of breast carcinoma in situ. Accurate coding is essential for appropriate treatment planning, billing, and compliance with healthcare regulations.
Other specified type of carcinoma in situ of right breast is characterized by abnormal cell growth within the breast tissue that has not invaded surrounding tissues. This condition may arise from various factors, including genetic predisposition and environmental influences. Early detection and intervention are crucial to prevent progression to invasive cancer.
ICD-10 Code D05.81 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.
In SOAP notes, ICD-10 Code D05.81 connects subjective patient reports and objective clinical findings to a formal diagnosis of carcinoma in situ. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.
Management of Other specified type of carcinoma in situ of right breast typically involves surgical intervention and may include adjuvant therapies. Prompt treatment is essential to prevent progression to invasive disease.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D05.81 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims processing and reimbursement.
| CPT Code | Description |
|---|---|
| 19301 | Mastectomy, partial (lumpectomy) |
| 19285 | Biopsy of breast, percutaneous, needle core |
| 77063 | Breast imaging, diagnostic mammography |
| 99406 | Smoking and tobacco use cessation counseling visit |
Common Questions About Using ICD-10 Code D05.81 for Other specified type of carcinoma in situ of right breast
What are the treatment options for carcinoma in situ?
Treatment options for carcinoma in situ typically include surgical intervention, such as lumpectomy or mastectomy, and may involve radiation therapy to reduce the risk of recurrence. Regular follow-up is essential for monitoring.
How is carcinoma in situ diagnosed?
Carcinoma in situ is diagnosed through imaging studies, such as mammograms, followed by biopsy to confirm the presence of abnormal cells. Clinical examination and patient history also play a crucial role.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a non-invasive form of cancer. While it does not spread beyond the ducts or lobules, it requires treatment to prevent progression to invasive cancer.
What is the prognosis for carcinoma in situ?
The prognosis for carcinoma in situ is generally favorable, especially with early detection and appropriate treatment. Regular monitoring is essential to ensure no progression to invasive disease.
Clinical Notes
SOAP notes
DAP notes
AI medical notes